Paper8340486
Visual recovery from radiation-induced optic neuropathy. The role of hyperbaric oxygen therapy.
Borruat FX and 4 others. J Clin Neuroophthalmol, 1993. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. Visual recovery from radiation-induced optic neuropathy. The role of hyperbaric oxygen therapy. Papers, record 8340486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8340486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Visual recovery from radiation-induced optic neuropathy. The role of hyperbaric oxygen therapy.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperbaric Oxygenation | Major topic |
| Optic Nerve Diseases | Major topic |
| Radiation Injuries | Major topic |
| Female | |
| Humans | |
| Magnetic Resonance Imaging | |
| Maxillary Sinus Neoplasms | |
| Melanoma | |
| Middle Aged | |
| Radiotherapy | |
| Visual Acuity | |
| Visual Fields |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39839516 | Radiomics model based on computed tomography images for prediction of radiation-induced optic neuropathy following radiotherapy of brain and head and neck tumors. | Heliyon | 2025 | https://conductscience.org/library/papers/39839516 | PubMed |
| 37227651 | Outcomes of systemic bevacizumab in radiation-induced optic neuropathy, case series. | J Neurooncol | 2023 | https://conductscience.org/library/papers/37227651 | PubMed |
| 35251172 | Long-Term Evaluation and Normal Tissue Complication Probability (NTCP) Models for Predicting Radiation-Induced Optic Neuropathy after Intensity-Modulated Radiation Therapy (IMRT) for Nasopharyngeal Carcinoma: A Large Retrospective Study in China. | J Oncol | 2022 | https://conductscience.org/library/papers/35251172 | PubMed |
| 33307631 | Efficacy of Hyperbaric Oxygen Therapy on Central Corneal Thickness, Intraocular Pressure, and Nerve Fiber Layer in Patients with Type 2 Diabetes: A Prospective Cohort Study. | Korean J Ophthalmol | 2021 | https://conductscience.org/library/papers/33307631 | PubMed |
| 33281925 | Radiation-induced neuropathies in head and neck cancer: prevention and treatment modalities. | Ecancermedicalscience | 2020 | https://conductscience.org/library/papers/33281925 | PubMed |
| 27630373 | Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma. | Trans Am Ophthalmol Soc | 2016 | https://conductscience.org/library/papers/27630373 | PubMed |
| 23196647 | Effects of radiotherapy on uveal melanomas and adjacent tissues. | Eye (Lond) | 2013 | https://conductscience.org/library/papers/23196647 | PubMed |
| 8759272 | Ocular oxygen measurement. | Br J Ophthalmol | 1996 | https://conductscience.org/library/papers/8759272 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8340486
GET https://conductscience.org/api/papers/v1/8340486/authors